GovWire

Advisory Council On The Misuse Of Drugs


Research and analysis: Synthetic cannabinoid receptor agonists

Research and analysis: Synthetic cannabinoid receptor agonists

This report provides an updated harms assessment to the ACMD's previous reports on synthetic cannabinoid receptor agonists.

0 comments Read Full Article
Correspondence: Response to the ACMD report on novel benzodiazepines

Correspondence: Response to the ACMD report on novel benzodiazepines

A review of the evidence of use and harms of novel benzodiazepines.

0 comments Read Full Article
Corporate report: ACMD members' register of interests

Corporate report: ACMD members' register of interests

Occupations, career history and interests of the members of the Advisory Council on the Misuse of Drugs (ACMD).

0 comments Read Full Article
New appointments to the ACMD

New appointments to the ACMD

Three new members of the Advisory Council for the Misuse of Drugs (ACMD) have been announced today.

0 comments Read Full Article
ACMD public evidence request on cognition enhancers

ACMD public evidence request on cognition enhancers

ACMD public request for written evidence on cognition enhancers (also known as ‘nootropics’ or ‘study drugs’).

0 comments Read Full Article
ACMD public evidence gathering: request for written evidence

ACMD public evidence gathering: request for written evidence

Forms for members of the public to provide written evidence on young people’s drug use and naloxone provision.

0 comments Read Full Article
Correspondence: Response to the ACMD recommendation: Epidyolex

Correspondence: Response to the ACMD recommendation: Epidyolex

A letter from the Minister of State for Fire and Policing to the ACMD, in response to the recommendation to Schedule Epidyolex.

0 comments Read Full Article
Research and analysis: Novel benzodiazepines: prevalence and harms in the UK

Research and analysis: Novel benzodiazepines: prevalence and harms in the UK

This report examines the evidence of prevalence and harms in the UK of several novel benzodiazepines and provides advice to the government.

0 comments Read Full Article
Correspondence: ACMD advice on administration rights for therapeutic radiographer independent prescribers

Correspondence: ACMD advice on administration rights for therapeutic radiographer independent prescribers

Letter from ACMD to ministers, providing advice on the administration rights of morphine by injection for therapeutic radiographer independent prescribers.

0 comments Read Full Article
Correspondence: Call for evidence: barriers to research with controlled drugs

Correspondence: Call for evidence: barriers to research with controlled drugs

Letter from the ACMD Barriers to Research working group to collect written evidence from researchers about barriers to legitimate research with controlled drugs.

0 comments Read Full Article
Correspondence: ACMD advice on COVID 19 emergency legislation to enable supply of controlled drugs

Correspondence: ACMD advice on COVID 19 emergency legislation to enable supply of controlled drugs

Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary advising on COVID-19 emergency measures to enable the supply of controlled drugs.

0 comments Read Full Article
Corporate report: Standard Operating Procedure for using evidence in ACMD reports

Corporate report: Standard Operating Procedure for using evidence in ACMD reports

A document developed by the Advisory Council on the Misuse of Drugs (ACMD) to outline the governing process for preparing evidence-based advice.

0 comments Read Full Article
ACMD public evidence gathering: request for written evidence

ACMD public evidence gathering: request for written evidence

Forms for members of the public to provide written evidence on young people’s drug use and naloxone provision.

0 comments Read Full Article
Correspondence: Letter from the ACMD to the Home Secretary: GHB, GBL, and related compounds

Correspondence: Letter from the ACMD to the Home Secretary: GHB, GBL, and related compounds

Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary in response to the 6 January letter on GHB and GBL.

0 comments Read Full Article
Correspondence: Call for evidence: barriers to research with controlled drugs

Correspondence: Call for evidence: barriers to research with controlled drugs

Letter from the ACMD Barriers to Research working group to collect written evidence from researchers about barriers to legitimate research with controlled drugs.

0 comments Read Full Article
Correspondence: Call for evidence: barriers to research with controlled drugs

Correspondence: Call for evidence: barriers to research with controlled drugs

Letter from the ACMD Barriers to Research working group to collect written evidence from researchers about barriers to legitimate research with controlled drugs.

0 comments Read Full Article
ACMD public evidence gathering days: young people’s drug use and naloxone provision

ACMD public evidence gathering days: young people’s drug use and naloxone provision

Register your interest in attending or providing evidence to the ACMD.

0 comments Read Full Article

ACMD public evidence gathering days: young people’s drug use and naloxone provision

ACMD public evidence gathering days: young people’s drug use and naloxone provision

Register your interest in attending or providing evidence to the ACMD.

0 comments Read Full Article

Correspondence: Advice on Epidyolex

Correspondence: Advice on Epidyolex

Letter to the Home Office regarding the appropriate Schedule for the cannabis-based product for medicinal use, Epidyolex, under the Misuse of Drugs Regulations 2001.

0 comments Read Full Article

Correspondence: Misuse of fentanyl and fentanyl analogues

Correspondence: Misuse of fentanyl and fentanyl analogues

This report advises government on the number and nature of known fentanyl analogues, risk factors, pharmacology, toxic effects and misuse and associated harms.

0 comments Read Full Article

Correspondence: Cannabis based products for medicinal use: assessing the impact

Correspondence: Cannabis based products for medicinal use: assessing the impact

A framework for the assessment of the impact of rescheduling cannabis-based products for medicinal use (CBPMs).

0 comments Read Full Article

Correspondence: Cannabis based products for medicinal use: assessing the impact

Correspondence: Cannabis based products for medicinal use: assessing the impact

A framework for the assessment of the impact of rescheduling cannabis-based products for medicinal use (CBPMs).

0 comments Read Full Article

Correspondence: Self commissioned workstreams for 2020

Correspondence: Self commissioned workstreams for 2020

Letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs, outlining our self-commissioned workstreams planned for 2020.

0 comments Read Full Article

Correspondence: Self commissioned workstreams for 2020

Correspondence: Self commissioned workstreams for 2020

Letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs, outlining our self-commissioned workstreams planned for 2020.

0 comments Read Full Article

Correspondence: 'Third generation' synthetic cannabinoids

Correspondence: 'Third generation' synthetic cannabinoids

Report to the Minister for Crime Prevention, which recommends a revised generic description of ‘third generation’ synthetic cannabinoids.

0 comments Read Full Article

Correspondence: ACMD advice: future use and purpose of Temporary Class Drug Orders

Correspondence: ACMD advice: future use and purpose of Temporary Class Drug Orders

Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the future use and purpose of Temporary Class Drug Orders (TCDOs).

0 comments Read Full Article

Correspondence: ACMD advice: future use and purpose of Temporary Class Drug Orders

Correspondence: ACMD advice: future use and purpose of Temporary Class Drug Orders

Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the future use and purpose of Temporary Class Drug Orders (TCDOs).

0 comments Read Full Article

Correspondence: ACMD advice: future use and purpose of Temporary Class Drug Orders

Correspondence: ACMD advice: future use and purpose of Temporary Class Drug Orders

Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the future use and purpose of Temporary Class Drug Orders (TCDOs).

0 comments Read Full Article

Correspondence: ACMD advice on independent prescribing by paramedics

Correspondence: ACMD advice on independent prescribing by paramedics

Letter from Advisory Council on the Misuse of Drugs (ACMD) to ministers, providing advice on independent prescribing of controlled drugs by paramedics.

0 comments Read Full Article

Correspondence: ACMD advice on independent prescribing by paramedics

Correspondence: ACMD advice on independent prescribing by paramedics

Letter from Advisory Council on the Misuse of Drugs (ACMD) to ministers, providing advice on independent prescribing of controlled drugs by paramedics.

0 comments Read Full Article

Correspondence: ACMD advice on independent prescribing by paramedics

Correspondence: ACMD advice on independent prescribing by paramedics

Letter from Advisory Council on the Misuse of Drugs (ACMD) to ministers, providing advice on independent prescribing of controlled drugs by paramedics.

0 comments Read Full Article

Research and analysis: Review of Psychoactive Substances Act 2016: ACMD contribution

Research and analysis: Review of Psychoactive Substances Act 2016: ACMD contribution

The Advisory Council on the Misuse of Drugs (ACMD) summarise their contribution to the impact review of the Psychoactive Substances Act 2016

0 comments Read Full Article

Research and analysis: Review of Psychoactive Substances Act 2016: ACMD contribution

Research and analysis: Review of Psychoactive Substances Act 2016: ACMD contribution

The Advisory Council on the Misuse of Drugs (ACMD) summarise their contribution to the impact review of the Psychoactive Substances Act 2016

0 comments Read Full Article

Corporate report: ACMD members' register of interests

Corporate report: ACMD members' register of interests

Occupations, career history and interests of the members of the Advisory Council on the Misuse of Drugs (ACMD).

0 comments Read Full Article

Chair reappointment to the Advisory Council on the Misuse of Drugs

Chair reappointment to the Advisory Council on the Misuse of Drugs

The Home Secretary, Sajid Javid has today announced the reappointment of Dr Owen Bowden-Jones as the chair of the Advisory Council on the Misuse of Drugs.

0 comments Read Full Article

Chair reappointment to the Advisory Council on the Misuse of Drugs

Chair reappointment to the Advisory Council on the Misuse of Drugs

The Home Secretary, Sajid Javid has today announced the reappointment of Dr Owen Bowden-Jones as the chair of the Advisory Council on the Misuse of Drugs.

0 comments Read Full Article

Research and analysis: Drug related harms in homeless populations

Research and analysis: Drug related harms in homeless populations

ACMD report providing advice to the government on the factors that make the homeless population vulnerable to substance misuse harms and how these can reduced.

0 comments Read Full Article

Report into homelessness and drug misuse published

Report into homelessness and drug misuse published

Safe housing key to tackling homeless drug misuse, says ACMD.

0 comments Read Full Article

Press release: Report into homelessness and drug misuse published

Press release: Report into homelessness and drug misuse published

Safe housing key to tackling homeless drug misuse, says ACMD.

0 comments Read Full Article

Number of older opiate users in treatment has tripled

Number of older opiate users in treatment has tripled

The number of older opiate users in treatment in England has tripled in just 12 years, a report by the ACMD reveals today.

0 comments Read Full Article

Number of older opiate users in treatment has tripled

Number of older opiate users in treatment has tripled

The number of older opiate users in treatment in England has tripled in just 12 years, a report by the ACMD reveals today.

0 comments Read Full Article

Independent report: ACMD report: ageing cohort of drug users

Independent report: ACMD report: ageing cohort of drug users

Report from the ACMD providing advice to the government on the changing age profile of people accessing drug treatment and the challenges faced by this cohort in the UK.

0 comments Read Full Article

ACMD: avoid Friday prison release to prevent drug relapse and deaths

ACMD: avoid Friday prison release to prevent drug relapse and deaths

Prison services could reduce drug-related harms by avoiding releasing vulnerable prisoners on a Friday, the ACMD has today advised the Home Secretary.

0 comments Read Full Article

Advice on 2,4 Dinitrophenol

Advice on 2,4 Dinitrophenol

Letter to the Home Office about the appropriate control mechanism for 2, 4-Dinitrophenol (DNP).

0 comments Read Full Article

Legitimate use of controlled drugs: research and healthcare

Legitimate use of controlled drugs: research and healthcare

Interim advice to the Home Office regarding the legitimate use of controlled drugs in research and healthcare.

0 comments Read Full Article

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: